Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastoma
Beigi Masihi, M.; Chambers, K.; Friedman, R.; Pampou, S.; Gudenas, B. L.; Torrejon, J.; Lee, C.; Furnari, G.; Chau, L. Q.; GC, S.; Lin, Y.; Chapman, O. S.; Skowron, P.; Garzia, L.; Taylor, M. D.; Chavez, L.; Ayrault, O.; Northcott, P. A.; Karan, C.; Wechsler-Reya, R. J.
Show abstract
Medulloblastoma (MB) is the most common malignant pediatric brain tumor, and Group 3 (G3, MYC-driven) MB has the worst prognosis. Despite advances in molecular classification, oncogenic drivers of G3 MB remain poorly defined. To identify such drivers, we profiled transcription factor expression across MB subgroups. Our analysis revealed Ras-responsive element binding protein 1 (RREB1) as one of the most highly expressed transcription factors in G3 MB. RREB1 knockdown impaired cell proliferation in vitro and prolonged survival in orthotopic xenograft models, suggesting it plays a key role in regulating tumor growth. Mechanistically, RREB1 acts by enhancing transcription of TGF-{beta} pathway genes. Upstream, RREB1 expression is controlled by c-MET signaling, and the MET inhibitor SU11274 decreased RREB1 levels and MB cell viability. Local delivery of SU11274 in tumor-bearing mice suppressed RREB1 expression and extended survival. These results establish the c-MET/RREB1 axis as a critical oncogenic regulator and a promising therapeutic target in in high-risk MB.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers 96%
- MaTAR25 LncRNA Regulates the Tensin1 Gene to Impact Breast Cancer Progression 96%
- GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer 96%
Similar papers in this journal
Similar papers in this journal
- EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes 96%
- NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy 96%
- Pharmacologically targeting KRASG12D in PDAC models:tumor cell intrinsic and extrinsic impact 96%
Similar papers in this journal
- Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers 96%
- The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival 96%
- Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53 95%
Similar papers in this journal
- Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq-guided combination with sapanisertib 96%
- Therapeutic targeting of SLC6A8 creatine transporter inhibits KRAS mutant and wildtype colon cancer and modulates human creatine levels 96%
- HIRA loss transforms FH-deficient cells 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.